Allied Market Research
image  Direct : +1 (617) 674-4143 | Toll Free : +1 (855) 711-1555





Noninvasive Cancer Diagnostics and Technologies Market - Global Share, Industry Overview, Analysis, Growth, Trends Opportunities and Forecast 2012 - 2020

Non-invasive diagnostic is a process of identifying the disease conditions with minimal incision in body during diagnosis. The global market for diagnostic/in-vitro diagnostics valued at $49.2 billion in 2012, which shows potential for market growth, especially in chronic diseases. Non-invasive cancer diagnostics is gaining importance over conventional diagnosis due to increase in incidences of chronic cancer such as breast cancer, and lung cancer. According to American Cancer Society, there were more than 1,660,290 new cases diagnosed in 2013. Commercialization of non-invasive cancer diagnosis is possible due to completion of Human Genome Project (HGP) that gives enormous diagnostic information based on genomic and proteomic. Increase in stringent regulatory guidelines and cost associated with diagnostics is hindering the growth of non-invasive cancer diagnostic market. The Ovarian Cancer National Alliance regulations for monitoring non-invasive diagnostics are issued by FDA, Medicare and Medicaid Services (CMS) and Social Security Administration (SSA).

The global non-invasive market has a huge potential in developing countries; however, cost of diagnosis is creating hurdles to tap this market. Hence, to overcome this problem, the diagnostic market has to be analyzed by the developing countries such as China, Japan, and India. This report provides key market drivers that are driving the market with impact analysis. The report gives intelligence about key regulatory guidelines issued by respective governments.

Key companies included in report are Precision Therapeutics, A&G Pharmaceutical, Affymetrix Inc., AVIVA Biosciences Corporation, BIOVIEW Inc., Laboratory Corporation of America Holdings (LabCorp), , Quest Diagnostics Incorporated Cancer Genetics Inc., Digene Corporation, Gen-Probe Incorporated, 

KEY BENEFITS

  • Key developmental strategies adopted by top market players engaged in this business so that companies involved in development non-invasive cancer diagnostic device can get competitive intelligence of their competitors
  • Market estimation for therapeutics techniques and geographic segment is derived from current market scenario and expected market trends
  • Market attractiveness analysis has been included for various product segments, therapeutics, techniques and geographic regions with detailed analysis of factors responsible for rapid growth of the market segments
  • In depth analysis of key market drivers, restraints and opportunities of non-invasive cancer diagnostic market with impact analysis
  • Value chain analysis, Porter’s five force model, top investment pockets (GE9 Cell Matrix) are analyzed and presented in detail in the report so that the decision makers can receive clear picture of cancer diagnosis market

KEY MARKET SEGMENTS

GLOBAL MARKET,  BY THERAPEUTICS

       • Solid tumors
       • Blood cancer
       • Lung Cancer
       • Breast Cancer
       • Others

GLOBAL MARKET,  BY TECHNIQUES
       • Clinical Chemistry
       • Immunochemistry/Immunoassay
       • Molecular Diagnostics
       • Other Clinical Instruments

GLOBAL MARKET,  BY GEOGRAPHY
       • North America
       • Europe
       • Asia-Pacific
       • RoW

KEY AUDIENCES
   • Medical devices manufacturing companies
   • Pharmaceutical companies
   • Government and Private Research Institutes
   • Academic Institutes


OUR VALUE
  • Most infallible methodology to ensure high level data integrity, accurate analysis and impeccable forecasts
  • Seamless analyst support for complete satisfaction
  • On-demand customization of scope of the report to exactly meet your needs
  • Targeted market view to eliminate redundant information to provide valued information and save time of the reader
  • Multiple delivery formats to improve data usability and time*
  • Quarterly revision of reports for up-to-date market information*
  • *For corporate users
LICENSE DETAILS
Pre-Book
Single User License $3950
Multi User License $6950
Corporate License $9950
VIEW LICENCE DETAILS
License Terms & Conditions
Our reports are copyrighted and hence, any redistribution, unauthorized copying, transmitting mechanically or electronically is strictly prohibited as per the U.S. and International copyright laws without prior written permission. As per the following license agreement, buyer of this report would be confined to use it according to the terms of license. In case the company wishes for an upgradation of the license, it should contact the publisher.





Databases
Subscriptions
Statistical Reports and References
Industry Reports
Geographic Reports
Company Reports
Consumer Surveys
Business Consulting
Channel Analytics
Peer Analysis
Consumer Insights
Product Performance and Analytics
Design your own Research
Research Methodology
Analyst Briefings
Press Releases
AMR In News
Top